Rock Springs Capital Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
Rock Springs Capital Management's BLUE Position: Q1 2020 in Review
Rock Springs Capital Management sold out of bluebird bio (BLUE) in Q1 2020, closing a stake of 2,702 shares — an estimated $3.07M sold.
Rock Springs Capital Management first reported a position in BLUE in Q4 2014 and held it in 21 quarters. The position peaked at $8.02M in Q4 2017. 247 funds tracked by Wall St. Rank hold BLUE as of Q1 2020.
- Rock Springs Capital Management reported no remaining bluebird bio position as of Q1 2020 after selling out during the quarter.
- Rock Springs Capital Management sold 2,702 bluebird bio shares in Q1 2020, an estimated $3.07M.
- Rock Springs Capital Management first reported a position in bluebird bio in Q4 2014 and held it in 21 quarters.
- Rock Springs Capital Management's bluebird bio position peaked at $8.02M in Q4 2017.
- 247 funds tracked by Wall St. Rank held bluebird bio as of Q1 2020.
Based on Rock Springs Capital Management's 13F filing for Q1 2020, filed 15 May 2020.